Google's DeepMind leads the market with Gemini, TPU chips, and cloud growth, making its valuations compelling compared to its ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

Hedge fund manager and entrepreneur Liang Wenfeng built an AI model on a tight budget despite US attempts to halt China’s ...

The other was an interview of Dario Amodei, founder and CEO of Anthropic and author of Machines of Loving Grace, by Zanny Minton Beddoes, editor of The Economist. The interview with Hassabis ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Alphabet's AI chip business could be worth $700 billion, potentially making it the most valuable part of the company.

A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, ...